Gilead Sciences (GILD) Finished Goods (2009 - 2015)

Gilead Sciences (GILD) reported Finished Goods of $852.0 million for Q4 2015, up 82.83% on a YoY basis from $466.0 million in Q4 2014, and up 82.83% quarter-over-quarter from $466.0 million in Q4 2014.

Gilead Sciences (GILD) Finished Goods (2009 - 2015) Analysis & Trends

Gilead Sciences has reported Finished Goods for 7 years, with the latest figure at $852.0 million in Q4 2015.

  • For the quarter ending Q4 2015, Finished Goods rose 82.83% year-over-year to $852.0 million; the trailing twelve-month figure through Dec 2015 stood at $852.0 million (up 82.83% YoY), and the FY2015 full-year result was $852.0 million, up 82.83% from the prior year.
  • Finished Goods for Q4 2015 stood at $852.0 million, up from $466.0 million in the prior quarter.
  • The five-year high for Finished Goods was $852.0 million in Q4 2015, with the low at $225.9 million in Q4 2011.
  • Historically, Finished Goods has averaged $487.3 million across 5 years, with a median of $466.0 million in 2014.
  • Annual changes were most pronounced in 2011 — Finished Goods sank 33.79% — and 2012, when it jumped 147.9%.
  • Gilead Sciences' Finished Goods stood at $225.9 million in 2011, then jumped by 147.9% to $559.9 million in 2012, then increased by 5.99% to $593.4 million in 2013, then retreated by 21.47% to $466.0 million in 2014, then soared by 82.83% to $852.0 million in 2015.
  • The last three Finished Goods figures came in at $852.0 million (Q4 2015), $466.0 million (Q4 2014), and $560.0 million (Q2 2014), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2015 852.00 Mn
Dec 31, 2014 466.00 Mn
Jun 30, 2014 559.98 Mn
Dec 31, 2013 593.44 Mn
Dec 31, 2012 559.91 Mn
Dec 31, 2011 225.86 Mn
Sep 30, 2011 295.79 Mn
Jun 30, 2011 384.72 Mn
Mar 31, 2011 448.43 Mn
Dec 31, 2010 341.14 Mn
Sep 30, 2010 439.32 Mn
Dec 31, 2009 326.15 Mn